Literature DB >> 15721125

Effect of cirrhosis and liver transplantation on the gender difference in QT interval.

Adegboyega Q Adigun1, Amar G Pinto, David A Flockhart, J Christopher Gorski, Lang Li, Stephen D Hall, Naga Chalasani.   

Abstract

The effect of gender on the QT interval in patients with cirrhosis before and after liver transplantation and the relation between the QT interval and changes in gender hormones after liver transplantation were assessed. The study showed that (1) physiologic gender difference in the QTc interval is abolished in cirrhosis, and it is not restored after liver transplantation, and (2) gender hormone concentrations had no effect on the QTc interval.

Entities:  

Mesh:

Year:  2005        PMID: 15721125     DOI: 10.1016/j.amjcard.2004.10.054

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  Hepato-cardiac disorders.

Authors:  Yasser Mahrous Fouad; Reem Yehia
Journal:  World J Hepatol       Date:  2014-01-27

2.  QT interval prolongation in end-stage liver disease cannot be explained by nonhepatic factors.

Authors:  Divyang Patel; Prabhpreet Singh; William Katz; Christopher Hughes; Kapil Chopra; Jan Němec
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-04-24       Impact factor: 1.468

Review 3.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

Review 4.  Arrhythmia risk in liver cirrhosis.

Authors:  Ioana Mozos
Journal:  World J Hepatol       Date:  2015-04-08

5.  Alterations in corrected QT interval following liver transplant in patients with end-stage liver disease.

Authors:  Andrew O Zurick; Bret J Spier; Thomas C Teelin; Katelin R Lorenze; Cesar Alberte; Steven Zacks; Mary J Lindstrom; Patrick R Pfau; Kimberly Selzman
Journal:  Clin Cardiol       Date:  2010-11       Impact factor: 2.882

6.  Cirrhotic cardiomyopathy: Isn't stress evaluation always required for the diagnosis?

Authors:  Mara Barbosa; Joana Guardado; Carla Marinho; Bruno Rosa; Isabel Quelhas; António Lourenço; José Cotter
Journal:  World J Hepatol       Date:  2016-01-28

7.  Diagnosis and Management of Cirrhotic Cardiomyopathy.

Authors:  Harpreet Kaur; Madhumita Premkumar
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

8.  Prevalence of pre-transplant electrocardiographic abnormalities and post-transplant cardiac events in patients with liver cirrhosis.

Authors:  Axel Josefsson; Michael Fu; Einar Björnsson; Evangelos Kalaitzakis
Journal:  BMC Gastroenterol       Date:  2014-04-05       Impact factor: 3.067

9.  The Correlation between Echocardiographic Findings and QT Interval in Cirrhotic Patients.

Authors:  Alireza Moaref; Mahmood Zamirian; Maryam Yazdani; Oveis Salehi; Mehrab Sayadi; Kamran Aghasadeghi
Journal:  Int Cardiovasc Res J       Date:  2014-04-01

10.  QT prolongation is associated with increased mortality in end stage liver disease.

Authors:  Sun Moon Kim; Bennet George; Diego Alcivar-Franco; Charles L Campbell; Richard Charnigo; Brian Delisle; Jonathan Hundley; Yousef Darrat; Gustavo Morales; Samy-Claude Elayi; Alison L Bailey
Journal:  World J Cardiol       Date:  2017-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.